Lenz Brian insider trades
Lenz Brian has filed 17 Form 4s with the SEC that we hold, all for Adma Biologics, INC. (ADMA), as EVP, CFO. Across all of them we count 2 purchases worth $50.0K and 2 sales worth $1.8M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 211,578 shares of Adma Biologics, INC. worth $973.3K, dated 2023-08-15. The first filing on our record is dated 2021-10-01 and the latest 2024-03-08.
Adma Biologics, INC. (ADMA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-25 | P, purchase reported on Form 4 | 30,000 | $30.0K | 2021-10-26 |
| 2022-12-09 | P, purchase reported on Form 4 | 6,993 | $20.0K | 2022-12-09 |
| 2023-08-15 | S, sale reported on Form 4 | 211,578 | $973.3K | 2023-08-17 |
| 2023-08-16 | S, sale reported on Form 4 | 178,184 | $792.9K | 2023-08-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1283260) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms